Skip to content

What is the new injection for seniors? Your 2025 Vaccination Guide

4 min read

According to the Centers for Disease Control and Prevention (CDC), adults aged 65 and older are at increased risk for severe complications from common respiratory illnesses. This guide explains what is the new injection for seniors, detailing the latest recommendations for vaccines against Respiratory Syncytial Virus (RSV), COVID-19, and influenza in 2025.

Quick Summary

Essential information on the newest injections recommended for older adults in 2025, covering updated COVID-19 and RSV vaccines. Details who should receive these shots and their benefits for enhanced protection against serious illness.

Key Points

  • New Injections for Seniors: In 2025, new and updated vaccines are available for Respiratory Syncytial Virus (RSV) and COVID-19, alongside specific high-dose flu shots for older adults.

  • RSV Vaccine (mResvia): A new RSV vaccine, mResvia (Moderna), was licensed in 2024 for adults 60 and older, joining Arexvy (GSK) and Abrysvo (Pfizer). All are single-administration injections.

  • Updated COVID-19 Vaccine: The 2025-2026 COVID-19 vaccine formula targets the LP.8.1 Omicron strain and is recommended in two administrations for adults 65 and older.

  • Enhanced Flu Shots: For seniors, high-dose or adjuvanted flu vaccines are recommended annually for a stronger immune response.

  • Vaccine Coadministration: Seniors can safely receive multiple vaccines, such as RSV, COVID-19, and flu shots, at the same visit, though a healthcare provider should be consulted.

  • Medicare Coverage: These recommended vaccines, including shingles and pneumococcal shots, are typically covered by Medicare Part B and D with no out-of-pocket costs for ACIP-recommended immunizations.

  • Consult a Doctor: All seniors should consult their healthcare provider to create a personalized vaccination plan based on their health status and risk factors.

In This Article

Updated Vaccines for Seniors in 2025

Staying up-to-date with vaccinations is a critical component of preventative healthcare for seniors. In 2025, several key vaccines have new recommendations or updated formulations aimed at providing better protection against circulating viruses. The most notable updates concern Respiratory Syncytial Virus (RSV) and COVID-19, with special formulations also recommended for annual influenza shots.

The Latest on Respiratory Syncytial Virus (RSV) Vaccines

New RSV vaccines have been licensed and recommended by the CDC for adults aged 60 and older. Three approved vaccines — Arexvy (GSK), Abrysvo (Pfizer), and mResvia (Moderna) — are licensed for older adults. A single administration is recommended for eligible adults and offers protection for at least one to two seasons. Vaccination in late summer or early fall (August-October) is recommended for best protection before RSV season. All adults 75 and older are recommended to get a single administration. Adults 50–74 at increased risk of severe RSV due to underlying health conditions should also get vaccinated.

The 2025-2026 COVID-19 Vaccine Update

COVID-19 vaccine formulations are updated annually. The 2025-2026 formulations target the LP.8.1 Omicron strain. Updated COVID-19 vaccines from Pfizer, Moderna, and Novavax are approved for adults aged 65 and older. The CDC recommended in October 2024 that adults 65 and older receive a second 2024-2025 COVID-19 vaccine six months after their last administration. Those who are moderately or severely immunocompromised may need additional doses based on clinical guidance.

Influenza (Flu) Vaccines for 2025-2026

Annual flu shots are important for seniors, with specific high-dose or adjuvanted versions recommended for a stronger immune response. High-dose (e.g., Fluzone High-Dose) and adjuvanted (e.g., Fluad) flu vaccines are preferred for those 65 and older as they are more effective than standard-dose options. The flu vaccine is updated annually to target the predicted common strains. Fall, ideally by the end of October, is the best time for older adults to get their annual flu vaccine.

Comparison of Recommended Vaccines for Seniors

Here is a comparison of key vaccines recommended for seniors in 2025.

Vaccine Type Recommended for Seniors (65+) Schedule Key Benefit for Seniors Notes
RSV (Arexvy, Abrysvo, mResvia) Yes Single administration Prevents severe RSV infection and hospitalization First licensed for older adults starting in 2023.
COVID-19 (Updated 2025-26) Yes Two administrations for 65+ (6 months apart) Updated formula targets current virus strains New FDA guidance and ACIP recommendations apply.
Influenza (High-Dose/Adjuvanted) Yes (Preferred) Annually Stronger immune response than standard flu shots Specific options like Fluzone High-Dose, Fluad, and Flublok.
Shingles (Shingrix) Yes (Recommended for 50+) Two administrations (2-6 months apart) Prevents shingles and long-term nerve pain Recommended even if previously vaccinated with older Zostavax.
Pneumococcal Yes (Recommended) Varies by age and history Prevents pneumonia and other serious infections Two types of vaccines may be used.

Important Consideration: Coadministration of Vaccines

Receiving multiple vaccines at the same visit is generally safe and often recommended to improve vaccination rates. Temporary side effects like pain or fever might increase. The RSV vaccine can be given with the flu or COVID-19 shot, though data on combined immune response is still being gathered. A healthcare provider can advise on the best timing.

Finding and Accessing the Vaccines

These vaccines are widely available at healthcare providers, pharmacies (like Walgreens and Safeway), and clinics. Medicare Part D and most private insurance cover ACIP-recommended vaccines like RSV and shingles with no out-of-pocket costs. Medicare Part B covers annual flu and COVID-19 shots. Confirm coverage with your provider.

Conclusion

In 2025, seniors have access to new and updated vaccines offering strong protection against serious respiratory illnesses. This includes multiple RSV vaccines, an updated COVID-19 shot, and special high-dose flu shots. Seniors should consult their healthcare provider to determine the best personalized vaccination plan. Staying informed and vaccinated helps older adults protect their health throughout the year.

Frequently Asked Questions (FAQs)

What are the main new injections for seniors in 2025?

The main new injections for seniors include the updated 2025-2026 COVID-19 vaccine targeting current circulating strains and the relatively new single-administration RSV vaccine, with several approved options available.

Is the RSV vaccine an annual shot like the flu shot?

A single administration is recommended for eligible adults, with protection lasting for at least one to two seasons. {Link: Washington State Department of Health doh.wa.gov}

How many COVID-19 shots do seniors need in 2025?

The CDC has recommended that all adults aged 65 and older receive two administrations of the updated 2024-2025 COVID-19 vaccine, with the doses separated by six months.

What are the side effects of the new RSV vaccine?

Common side effects can include fatigue, fever, headache, and pain or swelling at the injection site.

Can a senior get the flu shot, COVID shot, and RSV shot all at once?

Yes, coadministration of these vaccines is generally safe and often recommended. However, getting multiple shots at once may increase temporary side effects, such as fever or headache. Discussing the best approach with a healthcare provider is recommended.

Does Medicare cover these new senior injections?

Yes, Medicare typically covers these vaccines. Medicare Part B covers the annual flu and COVID-19 vaccines, while Medicare Part D covers other commercially available vaccines, like the RSV and shingles shots, with no out-of-pocket costs for ACIP-recommended vaccines.

What is Shingrix and is it new for seniors?

Shingrix is the recommended shingles vaccine for adults aged 50 and older. It is a newer and more effective vaccine than the older Zostavax, which was discontinued. Shingrix is a two-administration series recommended even for those who have previously had shingles or received Zostavax.

Do I need a doctor's prescription to get these vaccines?

You typically do not need a prescription for recommended vaccines like the flu, COVID-19, or shingles shots, which are widely available at pharmacies. However, it is always best to consult with your healthcare provider to confirm eligibility and discuss any potential risk factors.

Frequently Asked Questions

For 2025, there is an updated COVID-19 vaccine targeting current virus variants and newer single-administration RSV vaccines approved for adults 60 and older. Additionally, high-dose or adjuvanted flu shots are recommended annually for seniors.

The CDC recommends a single administration of the RSV vaccine for all adults aged 75 and older. It is also recommended for adults aged 50–74 who are at increased risk of severe RSV disease due to certain underlying health conditions.

For the 2025 season, the CDC has recommended a second administration of the updated COVID-19 vaccine for all adults 65 and older, to be administered six months after the first 2024-2025 dose. Annual updates to the vaccine are expected.

No, while high-dose and adjuvanted flu shots are preferred for those 65 and older for better protection, a standard-dose flu shot can still be given if the enhanced versions are not available. The CDC recommends getting the flu shot annually.

Common side effects include pain, redness, or swelling at the injection site. Some people may also experience temporary fatigue, headache, muscle pain, or a fever. These effects usually last 2 to 3 days.

While not brand new, Shingrix has been the preferred shingles vaccine since 2017 and replaced the older Zostavax vaccine. It is recommended for healthy adults 50 and older as a two-administration series and offers more than 90% protection.

You typically do not need a prescription for recommended vaccines like the flu, COVID-19, or shingles shots, which are widely available at pharmacies. However, it is always best to consult with your healthcare provider to confirm eligibility and discuss any potential risk factors.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.